https://scholars.lib.ntu.edu.tw/handle/123456789/588420
標題: | Reply | 作者: | CHIEH-KAI CHAN TAI-SHUAN LAI VIN-CENT WU |
公開日期: | 2017 | 出版社: | Lippincott Williams and Wilkins | 卷: | 35 | 期: | 12 | 起(迄)頁: | 2549-2550 | 來源出版物: | Journal of Hypertension | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85033797273&doi=10.1097%2fHJH.0000000000001549&partnerID=40&md5=678056f6546feab3dd248131eca8661c https://scholars.lib.ntu.edu.tw/handle/123456789/588420 |
ISSN: | 0263-6352 | DOI: | 10.1097/HJH.0000000000001549 | SDG/關鍵字: | adipocytokine; aldosterone; glucocorticoid; glucocorticoid receptor; hydrocortisone; mineralocorticoid antagonist; mineralocorticoid receptor; tissue inhibitor of metalloproteinase 1; hydrocortisone; adipocyte; adrenalectomy; cohort analysis; drug efficacy; heart fibroblast; hormone release; human; hydrocortisone blood level; Letter; long term care; metabolic syndrome X; osteoporosis; prevalence; primary hyperaldosteronism; priority journal; protein binding; protein expression; quality of life; risk factor; Cushing syndrome; diabetes mellitus; hyperaldosteronism; risk; Cushing Syndrome; Diabetes Mellitus; Humans; Hydrocortisone; Hyperaldosteronism; Risk |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。